![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 39/395 | (2006.01) |
A61K 45/06 | (2006.01) | ||
A61K 31/663 | (2006.01) | ||
C07K 16/18 | (2006.01) | ||
G01N 33/68 | (2006.01) |
(11) | Number of the document | 2203478 |
(13) | Kind of document | T |
(96) | European patent application number | 08838428.4 |
Date of filing the European patent application | 2008-10-10 | |
(97) | Date of publication of the European application | 2010-07-07 |
(45) | Date of publication and mention of the grant of the patent | 2013-11-20 |
(46) | Date of publication of the claims translation | 2014-03-25 |
(86) | Number | PCT/EP2008/063691 |
Date | 2008-10-10 |
(87) | Number | WO 2009/047356 |
Date | 2009-04-16 |
(30) | Number | Date | Country code |
07118414 | 2007-10-12 | EP | |
08151911 | 2008-02-25 | EP | |
08161342 | 2008-07-29 | EP |
(72) |
KNEISSEL, Michaela, CH
HALLEUX, Christine, CH
HU, Shou-Ih, US
DIEFENBACH-STREIBER, Beate, DE
PRASSLER, Josef, DE
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Kompozicijos ir būdai, skirti panaudoti antikūnams prieš sklerostiną |
COMPOSITIONS AND METHODS FOR USE OF ANTIBODIES AGAINST SCLEROSTIN |
Payment date | Validity (years) | Amount | |
2024-09-03 | 17 | 347.00 EUR |
2025-10-10 |